Viemed Healthcare (NASDAQ:VMD) President Michael Moore Sells 40,232 Shares

Viemed Healthcare, Inc. (NASDAQ:VMD) President Michael Moore sold 40,232 shares of the firm’s stock in a transaction that occurred on Thursday, March 19th. The shares were sold at an average price of $9.21, for a total value of $370,536.72. Following the completion of the transaction, the president owned 1,650,812 shares of the company’s stock, valued at approximately $15,203,978.52. The trade was a 2.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Michael Moore also recently made the following trade(s):

• On Friday, March 20th, Michael Moore sold 65,000 shares of Viemed Healthcare stock. The shares were sold at an average price of $8.77, for a total value of $570,050.00.
• On Wednesday, March 18th, Michael Moore sold 31,570 shares of Viemed Healthcare stock. The stock was sold at an average price of $9.42, for a total value of $297,389.40.

Viemed Healthcare Stock Down 5.5%

VMD traded down $0.51 during trading on Friday, reaching $8.71. The stock had a trading volume of 703,686 shares, compared to its average volume of 245,033. The company has a current ratio of 1.18, a quick ratio of 1.06 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $336.21 million, a price-to-earnings ratio of 23.54 and a beta of 1.23. The stock’s 50 day moving average is $8.30 and its two-hundred day moving average is $7.37. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $10.06.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.02. The firm had revenue of $76.18 million for the quarter, compared to analysts’ expectations of $77.70 million. Viemed Healthcare had a net margin of 5.53% and a return on equity of 10.72%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Viemed Healthcare in a report on Monday, December 29th. Zacks Research upgraded Viemed Healthcare to a “hold” rating in a research note on Thursday, January 8th. Finally, Wall Street Zen raised Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

Institutional Trading of Viemed Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Forager Capital Management LLC raised its holdings in Viemed Healthcare by 12.1% in the second quarter. Forager Capital Management LLC now owns 2,136,472 shares of the company’s stock worth $14,763,000 after buying an additional 230,670 shares during the last quarter. Wasatch Advisors LP grew its holdings in shares of Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after buying an additional 240,346 shares during the last quarter. Goldman Sachs Group Inc. increased its position in shares of Viemed Healthcare by 3.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,447,033 shares of the company’s stock valued at $10,751,000 after acquiring an additional 49,962 shares in the last quarter. Geode Capital Management LLC raised its holdings in Viemed Healthcare by 2.0% in the 2nd quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock worth $5,519,000 after acquiring an additional 15,353 shares during the last quarter. Finally, State Street Corp raised its holdings in Viemed Healthcare by 1.7% in the 4th quarter. State Street Corp now owns 675,190 shares of the company’s stock worth $5,017,000 after acquiring an additional 11,385 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.